Chairman and CEO Ian Read said Pfizer Inc. (NYSE:PFE) will likely end its agreement to defer drug price increases and return to "business as normal" by year end.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,